Entera Health competitors

Shai Gozani, founded NeuroMetrix, Inc. in 1996 as a spin-off from the Massachusetts Institute of Technology. He currently serves as Chairman of the board of directors and as our President and Chief Executive Officer. Shai has led the Company from a venture capital backed start-up, through an initial public offering on Nasdaq, through development of a successful diagnostics business, and presently into the wearable technology sector. Over 2.5 million patients have benefited from the Company’s technology over the past 17 years.Shai has published over 30 peer-reviewed scientific articles and has been awarded over 40 US and international patents. He holds a B.A. degree in Computer Science, a M.S. degree in Electrical Engineering & Computer Science (Biomedical Engineering Focus) and a Ph.D. in Neurobiology, from the University of California, Berkeley. Shai also received an M.D. from Harvard Medical School and the Harvard-MIT Division of Health Sciences and Technology at M.I.T.

Kook Books is a Chief Executive Officer at I-Flow and is based in Haven, Kansas.

John Russell is a Board Member at Cardiva Medical Inc and President/CEO at Cardiva Medical Inc and is based in Santa Clara, California. He has worked as VP & General Manager, Latitude Patient Management at Boston Scientific; Business Development Associate at ELI LILLY & CO; and Sales Representative, CRM at Boston Scientific. John works or has worked at Edwards Laboratories and works or has worked as VP/General Manager at Guidant Boston Scientific. He studied at Duke University, UNIVERSITY OF NORTH CAROLINA, and University of North Carolina at Chapel Hill.

My work experience has been at the intersection of science and business. Currently I'm leading a life science startup formed to commercialize novel platform technologies for protein purification.

Mr. Mark R. Straley joined Agendia Inc. in August 2015 as the company’s CEO, bringing more than 25 years of international experience developing and commercializing clinical diagnostics and laboratory services. Most recently he served as President, Anatomical Pathology of Thermo Fisher Scientific of Waltham, Massachusetts. Prior to this position he was President and CEO of Metamark Genetics of Cambridge, Massachusetts, a biotech company focusing on the development of prognostic and predictive diagnostic tests for personalized treatment of cancer patients. From 2005 to 2010, Mark held positions at Ortho Clinical Diagnostics, a J&J company, first as Worldwide Vice President of Marketing and then as Worldwide President. Prior to his assignment with J&J, Mark worked for such brand name companies as Bayer Healthcare and Abbott Laboratories where he held positions of increasing responsibility. Mark earned a Bachelor of Science degree in Marketing from Miami University.